- JP-listed companies
- Fuji Pharma Co.,Ltd.
- Financials
- EBITDA margin (%)
Fuji Pharma Co.,Ltd. (4554)
Market cap
¥55.2B
P/E ratio
24.2x
Develops and manufactures specialized injectable medications for hospitals and medical distributors, focusing on hormone treatments and medical imaging contrast agents.
| Period End | EBITDA margin (%) (Million JPY) | YoY (%) |
|---|